SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000792977-16-000005
Filing Date
2016-11-04
Accepted
2016-11-03 17:42:21
Documents
93
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q amag9301610-q.htm 10-Q 1482579
2 EXHIBIT 31.1 ex311q32016.htm EX-31.1 16282
3 EXHIBIT 31.2 ex312q32016.htm EX-31.2 16054
4 EXHIBIT 32.1 ex321q32016.htm EX-32.1 8150
5 EXHIBIT 32.2 ex322q32016.htm EX-32.2 8395
  Complete submission text file 0000792977-16-000005.txt   9352395

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT amag-20160930.xml EX-101.INS 2178914
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amag-20160930.xsd EX-101.SCH 68029
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amag-20160930_cal.xml EX-101.CAL 141065
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amag-20160930_def.xml EX-101.DEF 359055
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amag-20160930_lab.xml EX-101.LAB 892031
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amag-20160930_pre.xml EX-101.PRE 542430
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10865 | Film No.: 161973002
SIC: 2834 Pharmaceutical Preparations